(Q34283042)

English

A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

multicenter clinical trial

0 references

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

D William Molloy

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

T I Standish

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Q Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

G Guyatt

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

DARAD Study Group

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

21 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

463-470

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Cornell Scale for Depression in Dementia

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Anti-amyloidogenic activity of tetracyclines: studies in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

The B-Value: A Tool for Monitoring Data

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Risk and predictability of drug interactions in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Validity and reliability of the Dysfunctional Behaviour Rating Instrument

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Comparison of the quick mild cognitive impairment (Qmci) screen and the SMMSE in screening for mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Tau suppression in a neurodegenerative mouse model improves memory function

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

The method of minimization for allocation to clinical trials. a review

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Improved reliability of the Standardized Alzheimer's Disease Assessment Scale (SADAS) compared with the Alzheimer's Disease Assessment Scale (ADAS).

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia?

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

21 January 2018

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for mild cognitive impairment: comparing the SMMSE and the ABCS.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3846

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.3846

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34283042&oldid=1545171375"